AI-Assisted Village Doctors and Rural Primary Healthcare: A Randomized Controlled Trial in China
How to cite
Lin, Wei; Yuan, Zhe. 2026. "AI-Assisted Village Doctors and Rural Primary Healthcare: A Randomized Controlled Trial in China." AEA RCT Registry. AEARCTR-0019289. https://doi.org/10.1257/rct.19289-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Village doctors in rural China are often few in number, aging, and have limited formal training, while chronic disease burdens are rising. This study evaluates whether giving village doctors access to an AI health assistant app ("Ant AFu," developed by Ant Group), along with structured training and support, changes how they deliver care. We conduct a village-level randomized controlled trial in a mountainous county in Guizhou Province, China, covering all 140 administrative villages. Villages are randomly assigned within townships to one of four groups: two groups where village doctors receive AI training and app access (in one of these, villagers are also encouraged to use the app), and two groups that continue current practice during the study period and receive delayed access afterward. We measure outcomes including how many patients doctors see, the quality of diagnosis and prescribing (assessed through case reviews, clinical scenarios, and unannounced standardized-patient visits), and patient recovery, using doctor surveys, monthly case records, and phone follow-ups with patients. We also study how doctors actually use the app, drawing on de-identified usage data, and whether any improvements persist after access to the tool is temporarily withdrawn for a subset of doctors.
Intervention
Village doctors in treatment villages receive standardized training on an AI health assistant app ("Ant AFu," developed by Ant Group) and supported access to the app for use in their daily clinical work. Training covers the app's core functions, guidance on when AI input is and is not appropriate, how to incorporate the tool into diagnosis, prescribing, chronic-disease follow-up, and home visits, and how to recognize high-risk cases requiring referral. Training is followed by hands-on practice with simulated and common real-world cases, and by several weeks of follow-up support (group chat/phone-based Q&A and periodic check-ins) after initial rollout, plus periodic refresher sessions and targeted outreach to low-usage doctors during the intervention period. There are two treatment arms: in one, only village doctors receive training and app access; in the other, villagers in the same villages are also encouraged and supported to use the app themselves. Villages in the two control arms continue current practice during the study period and are offered the same training after the endline survey (delayed treatment).
Experimental design
This is a village-level cluster-randomized controlled trial conducted in a mountainous county in Guizhou Province, China, covering all 140 administrative villages in the county. After a baseline survey of village doctors and clinics, villages are randomly assigned within townships (stratified randomization) to one of four arms of 35 villages each: (1) Treatment 1, in which village doctors receive standardized training and supported access to an AI health assistant app; (2) Treatment 2, which adds village-level promotion of the app to residents; and (3)-(4) two control arms that continue existing practice during the study period, with the same training offered after the study ends. Randomization is stratified within townships to balance village population, doctor gender, and doctor education. The intervention period lasts approximately 6 months, with a baseline survey beforehand and an endline survey afterward (total study duration approximately 12-13 months). Outcomes are measured through doctor surveys, monthly case-record collection, sampled patient phone follow-up, household surveys, and standardized clinical assessment methods, with analysis conducted at the village level using intention-to-treat comparisons and village-clustered standard errors.
Design details
Cited by
No citation data available for this registration yet.